✦ LIBER ✦

Pentostatin, cyclophosphamide, and rituximab show significant clinical activity in patients with previously untreated chronic lymphocytic leukemia

✍ Scribed by Nicole Lamanna; Mark A. Weiss

Book ID: 107546537
Publisher: Current Science Inc.
Year: 2007
Tongue: English
Weight: 116 KB
Volume: 9
Category: Article
ISSN: 1523-3790
DOI: 10.1007/s11912-007-0044-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemoimmunotherapy with modified dosing

Chemoimmunotherapy with modified dosing of fludarabine, cyclophosphamide, and rituximab shows significant clinical activity in patients with previously untreated chronic lymphocytic leukemia

✍ Nicole Lamanna; Mark A. Weiss 📂 Article 📅 2009 🏛 Current Science Inc. 🌐 English ⚖ 164 KB

Pentostatin and rituximab therapy for pr

Pentostatin and rituximab therapy for previously untreated patients with B-cell chronic lymphocytic leukemia

✍ Neil E. Kay; Wenting Wu; Brian Kabat; Betsy LaPlant; Thomas S. Lin; John C. Byrd 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB 👁 1 views

Pentostatin, cyclophosphamide, and ritux

Pentostatin, cyclophosphamide, and rituximab regimen in older patients with chronic lymphocytic leukemia

✍ Tait D. Shanafelt; Thomas Lin; Susan M. Geyer; Clive S. Zent; Nelson Leung; Bria 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB 👁 1 views

## Abstract ## BACKGROUND. The prevalence of chronic lymphocytic leukemia (CLL) increases with age. Although chemoimmunotherapy (CIT) has dramatically improved response rates in patients with CLL, some CIT regimens are not well tolerated by many patients ≥70 years of age. ## METHODS. Sixty‐four

The Addition of Rituximab to Fludarabine

The Addition of Rituximab to Fludarabine and Cyclophosphamide Improves Progression-free Survival in Patients with Previously Treated Chronic Lymphocytic Leukemia

✍ Amit Mahipal; Mark Weiss 📂 Article 📅 2010 🏛 Current Science Inc. 🌐 English ⚖ 80 KB

The addition of rituximab to fludarabine

The addition of rituximab to fludarabine improves clinical outcome in untreated patients with ZAP-70-negative chronic lymphocytic leukemia

✍ Giovanni Del Poeta; Maria Ilaria Del Principe; Maria Antonietta Irno Consalvo; L 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB 👁 1 views

Chemoimmunotherapy may overcome the adve

Chemoimmunotherapy may overcome the adverse prognostic significance of 11q deletion in previously untreated patients with chronic lymphocytic leukemia

✍ Apostolia-Maria Tsimberidou; Constantine Tam; Lynne V. Abruzzo; Susan O'Brien; W 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB